butabarbital decreases consequences of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers may well lower sufentanil levels and efficacy, potentially precipitating withdrawal syndrome in sufferers who may have formulated Bodily dependence to sufentanil. D